Key result
A three-gene panel consisting of IL1R2, IRAK3, and THBD accurately discriminated acute myocardial infarction from control samples with an AUC of 0.941 in the validation cohort.
Why the study?
The study was designed to explore potential diagnostic markers for acute myocardial infarction and investigate the significance of immune cell infiltration in this pathology.
Can gene biomarkers (IL1R2, IRAK3, THBD) accurately diagnose acute myocardial infarction compared to controls?
Case-Control (n=175)
Can gene biomarkers (IL1R2, IRAK3, THBD) accurately diagnose acute myocardial infarction compared to controls?
IL1R2, IRAK3, and THBD were identified as potential diagnostic gene biomarkers for acute myocardial infarction with high discriminatory ability.
Answers are grounded in this paper and cite their sources.
Requires prospective validation before diagnostic use; leaves open added value over current AMI biomarkers.
Objective: The present study was designed to explore potential diagnostic markers for acute myocardial infarction (AMI) and investigate the significance of immune cells infiltration in this pathology. Methods: Two public available gene expression profiles (GSE66360 and GSE48060 datasets) from human AMI and control samples were downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified between 80 AMI and 71 control samples. Least absolute shrinkage and selection operator (LASSO) model and support vector machines recursive feature elimination (SVM-RFE) analysis were performed to identify the candidate biomarkers. From the receiver operating characteristic (ROC) curve, the area under the ROC curve (AUC) value was obtained and used for evaluating discriminatory ability. The expression level and diagnostic value of biomarkers in AMI were further validated in GSE60993 dataset (17 AMI patients and 7 controls). The compositional patterns of 22 types of immune cell fraction in AMI were estimated based on the merged cohorts using Cell type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT). Results: A total of 27 genes were identified. The identified DEGs are mainly involved in carbohydrate binding, Kawasaki disease, atherosclerosis, and arteriosclerotic cardiovascular disease. Gene-sets related to atherosclerosis signaling, primary immunodeficiency, IL-17 and TNF signaling pathways were differentially activated in AMI compared to control. IL1R2, IRAK3 and THBD were identified as diagnostic markers of AMI (AUC = 0.877), and validated in the GSE60993 dataset (AUC = 0.941). Immune cell infiltration analysis revealed that IL1R2, IRAK3 and THBD were correlated with neutrophils, monocytes, M2 macrophages, CD4+ resting memory T cells, T cells gamma delta, and activated NK cells. Conclusion: IL1R2, IRAK3 and THBD can be used as diagnostic markers of AMI, and provides novel evidence and clues for future research of the occurrence and molecular mechanisms of AMI.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2020) conducted a case-control in Acute Myocardial Infarction (n=175). Expression of IL1R2, IRAK3, and THBD genes vs. Normal control samples was evaluated on Diagnostic accuracy (Area Under the Curve) for acute myocardial infarction (AUC 0.941, 95% CI 0.764-0.996). A three-gene panel consisting of IL1R2, IRAK3, and THBD accurately discriminated acute myocardial infarction from control samples with an AUC of 0.941 in the validation cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: